Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Refinement and Assessment of New Magnetic Resonance Imaging Technologies for Neurological Exams

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
General Electric
Philips Medical Systems
Information provided by (Responsible Party):
Ashok Srinivasan, M.D., University of Michigan
ClinicalTrials.gov Identifier:
NCT00739518
First received: August 20, 2008
Last updated: June 29, 2016
Last verified: June 2016
  Purpose
This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the brain, spine head and neck regions.

Condition Intervention
Nervous System Diseases
Procedure: MRI

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies

Resource links provided by NLM:


Further study details as provided by University of Michigan:

Primary Outcome Measures:
  • Improvement in quality of MRI studies in Neuroradiology [ Time Frame: 1 year ] [ Designated as safety issue: No ]

    Specific Measurement Are:

    1. Scan speed - is the new method as fast or faster than regular method(s)
    2. Signal to noise - Subjectively, or quantitatively do we get the same, better, or new contrast compared to the regular methods(s).
    3. Image contrast - Subjectively, or quantitatively do we get the same or better resolution compared to the regular method(s).
    4. Spatial resolution - Subjectively, or quantitatively do we get the same or better resolution compared to the regular method(s).
    5. Artifact - Subjectively, or quantitatively do we get the better artifact reduction compared to the regular method(s).
    6. Ergonomics - Is the new software easier to work or offer more information more cleanly than the regular software
    7. Patient comfort - Subjectively, does the new software and/or hardware make the patient's MRI experience more comfortable.


Estimated Enrollment: 500
Study Start Date: October 2004
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
NEW technology MRI
Procedure: MRI
Neurological MRI with new technology evaluation

Detailed Description:

This study is being done to assess new Magnetic Resonance Imaging (MRI) technologies such as new hardware or software designed to improve MRI examinations of the brain, spine, and head & neck regions.

Software and hardware are constantly being improved, new machines replace old machines, software is updated and improved as are the devices used to produce better MRI images.

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • If you are a male or a non-pregnant female patient
  • Normal volunteer
  • presenting to MRI for a clinically-ordered neurological or head and neck MRI exam

Exclusion Criteria:

  • Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator.
  • Pregnant patients or patients who are lactating.
  • A patient who is claustrophobic
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00739518

Locations
United States, Michigan
University of Michigan Health System
Ann Arbor, Michigan, United States, 48109
Sponsors and Collaborators
University of Michigan
General Electric
Philips Medical Systems
Investigators
Principal Investigator: Ashok Srivinasan, MD University of Michigan
  More Information

Responsible Party: Ashok Srinivasan, M.D., Principal Investigator, University of Michigan
ClinicalTrials.gov Identifier: NCT00739518     History of Changes
Other Study ID Numbers: HUM00041731 
Study First Received: August 20, 2008
Last Updated: June 29, 2016
Health Authority: United States: Institutional Review Board
Individual Participant Data  
Plan to Share IPD: No

Keywords provided by University of Michigan:
Neurological
MRI

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on September 23, 2016